Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype
ABSTRACT The outcome of Mycobacterium tuberculosis infection and the immunological response to the bacillus Calmette-Guerin (BCG) vaccine are highly variable in humans. Deciphering the relative importance of host genetics, environment, and vaccine preparation for the efficacy of BCG has proven diffi...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
American Society for Microbiology
2016
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f64389b5049e4b54bef00318049e02af |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f64389b5049e4b54bef00318049e02af |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f64389b5049e4b54bef00318049e02af2021-11-15T15:50:15ZTuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype10.1128/mBio.01516-162150-7511https://doaj.org/article/f64389b5049e4b54bef00318049e02af2016-11-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01516-16https://doaj.org/toc/2150-7511ABSTRACT The outcome of Mycobacterium tuberculosis infection and the immunological response to the bacillus Calmette-Guerin (BCG) vaccine are highly variable in humans. Deciphering the relative importance of host genetics, environment, and vaccine preparation for the efficacy of BCG has proven difficult in natural populations. We developed a model system that captures the breadth of immunological responses observed in outbred individual mice, which can be used to understand the contribution of host genetics to vaccine efficacy. This system employs a panel of highly diverse inbred mouse strains, consisting of the founders and recombinant progeny of the “Collaborative Cross” project. Unlike natural populations, the structure of this panel allows the serial evaluation of genetically identical individuals and the quantification of genotype-specific effects of interventions such as vaccination. When analyzed in the aggregate, our panel resembled natural populations in several important respects: the animals displayed a broad range of susceptibility to M. tuberculosis, differed in their immunological responses to infection, and were not durably protected by BCG vaccination. However, when analyzed at the genotype level, we found that these phenotypic differences were heritable. M. tuberculosis susceptibility varied between lines, from extreme sensitivity to progressive M. tuberculosis clearance. Similarly, only a minority of the genotypes was protected by vaccination. The efficacy of BCG was genetically separable from susceptibility to M. tuberculosis, and the lack of efficacy in the aggregate analysis was driven by nonresponsive lines that mounted a qualitatively distinct response to infection. These observations support an important role for host genetic diversity in determining BCG efficacy and provide a new resource to rationally develop more broadly efficacious vaccines. IMPORTANCE Tuberculosis (TB) remains an urgent global health crisis, and the efficacy of the currently used TB vaccine, M. bovis BCG, is highly variable. The design of more broadly efficacious vaccines depends on understanding the factors that limit the protection imparted by BCG. While these complex factors are difficult to disentangle in natural populations, we used a model population of mice to understand the role of host genetic composition in BCG efficacy. We found that the ability of BCG to protect mice with different genotypes was remarkably variable. The efficacy of BCG did not depend on the intrinsic susceptibility of the animal but, instead, correlated with qualitative differences in the immune responses to the pathogen. These studies suggest that host genetic polymorphism is a critical determinant of vaccine efficacy and provide a model system to develop interventions that will be useful in genetically diverse populations.Clare M. SmithMegan K. ProulxAndrew J. OliveDominick LaddyBibhuti B. MishraCaitlin MossNuria Martinez GutierrezMichelle M. BellerosePalmira Barreira-SilvaJia Yao PhuahRichard E. BakerSamuel M. BeharHardy KornfeldThomas G. EvansGillian BeamerChristopher M. SassettiAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 7, Iss 5 (2016) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Microbiology QR1-502 |
| spellingShingle |
Microbiology QR1-502 Clare M. Smith Megan K. Proulx Andrew J. Olive Dominick Laddy Bibhuti B. Mishra Caitlin Moss Nuria Martinez Gutierrez Michelle M. Bellerose Palmira Barreira-Silva Jia Yao Phuah Richard E. Baker Samuel M. Behar Hardy Kornfeld Thomas G. Evans Gillian Beamer Christopher M. Sassetti Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype |
| description |
ABSTRACT The outcome of Mycobacterium tuberculosis infection and the immunological response to the bacillus Calmette-Guerin (BCG) vaccine are highly variable in humans. Deciphering the relative importance of host genetics, environment, and vaccine preparation for the efficacy of BCG has proven difficult in natural populations. We developed a model system that captures the breadth of immunological responses observed in outbred individual mice, which can be used to understand the contribution of host genetics to vaccine efficacy. This system employs a panel of highly diverse inbred mouse strains, consisting of the founders and recombinant progeny of the “Collaborative Cross” project. Unlike natural populations, the structure of this panel allows the serial evaluation of genetically identical individuals and the quantification of genotype-specific effects of interventions such as vaccination. When analyzed in the aggregate, our panel resembled natural populations in several important respects: the animals displayed a broad range of susceptibility to M. tuberculosis, differed in their immunological responses to infection, and were not durably protected by BCG vaccination. However, when analyzed at the genotype level, we found that these phenotypic differences were heritable. M. tuberculosis susceptibility varied between lines, from extreme sensitivity to progressive M. tuberculosis clearance. Similarly, only a minority of the genotypes was protected by vaccination. The efficacy of BCG was genetically separable from susceptibility to M. tuberculosis, and the lack of efficacy in the aggregate analysis was driven by nonresponsive lines that mounted a qualitatively distinct response to infection. These observations support an important role for host genetic diversity in determining BCG efficacy and provide a new resource to rationally develop more broadly efficacious vaccines. IMPORTANCE Tuberculosis (TB) remains an urgent global health crisis, and the efficacy of the currently used TB vaccine, M. bovis BCG, is highly variable. The design of more broadly efficacious vaccines depends on understanding the factors that limit the protection imparted by BCG. While these complex factors are difficult to disentangle in natural populations, we used a model population of mice to understand the role of host genetic composition in BCG efficacy. We found that the ability of BCG to protect mice with different genotypes was remarkably variable. The efficacy of BCG did not depend on the intrinsic susceptibility of the animal but, instead, correlated with qualitative differences in the immune responses to the pathogen. These studies suggest that host genetic polymorphism is a critical determinant of vaccine efficacy and provide a model system to develop interventions that will be useful in genetically diverse populations. |
| format |
article |
| author |
Clare M. Smith Megan K. Proulx Andrew J. Olive Dominick Laddy Bibhuti B. Mishra Caitlin Moss Nuria Martinez Gutierrez Michelle M. Bellerose Palmira Barreira-Silva Jia Yao Phuah Richard E. Baker Samuel M. Behar Hardy Kornfeld Thomas G. Evans Gillian Beamer Christopher M. Sassetti |
| author_facet |
Clare M. Smith Megan K. Proulx Andrew J. Olive Dominick Laddy Bibhuti B. Mishra Caitlin Moss Nuria Martinez Gutierrez Michelle M. Bellerose Palmira Barreira-Silva Jia Yao Phuah Richard E. Baker Samuel M. Behar Hardy Kornfeld Thomas G. Evans Gillian Beamer Christopher M. Sassetti |
| author_sort |
Clare M. Smith |
| title |
Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype |
| title_short |
Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype |
| title_full |
Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype |
| title_fullStr |
Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype |
| title_full_unstemmed |
Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype |
| title_sort |
tuberculosis susceptibility and vaccine protection are independently controlled by host genotype |
| publisher |
American Society for Microbiology |
| publishDate |
2016 |
| url |
https://doaj.org/article/f64389b5049e4b54bef00318049e02af |
| work_keys_str_mv |
AT claremsmith tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT megankproulx tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT andrewjolive tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT dominickladdy tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT bibhutibmishra tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT caitlinmoss tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT nuriamartinezgutierrez tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT michellembellerose tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT palmirabarreirasilva tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT jiayaophuah tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT richardebaker tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT samuelmbehar tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT hardykornfeld tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT thomasgevans tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT gillianbeamer tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype AT christophermsassetti tuberculosissusceptibilityandvaccineprotectionareindependentlycontrolledbyhostgenotype |
| _version_ |
1718427497560801280 |